Transurethral microwave thermotherapy in the management of lower urinary tract symptoms from benign prostatic obstruction: Follow-up after five years

Scandinavian Journal of Urology and Nephrology

Volumn 34, Issue 5, 2000, Pages 304-308

  Daehlin L ^a   Frugard J ^a  

^a Diakonissehjemmets sykehus ^*  (Norway)

Author keywords

Microwaves; Prostatic hyperplasia; Thermotherapy

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUALITY OF LIFE; RESIDUAL URINE; TRANSURETHRAL MICROWAVE THERMOTHERAPY; TREATMENT OUTCOME; URINARY TRACT OBSTRUCTION; URINE FLOW RATE;

AGED; DIATHERMY; FOLLOW-UP STUDIES; HUMANS; MALE; MICROWAVES; MIDDLE AGED; PROSTATIC HYPERPLASIA; TIME FACTORS; URETHRA; URETHRAL OBSTRUCTION;

EID: 17744381167     PISSN: 00365599     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655900750048314     Document Type: Article

References (25)

1. Clinical response to transurethral microwave thermotherapy is thermal dose dependent
2. Sham versus transurethral microwave thermotherapy in patients with symptoms of benign prostatic bladder outflow obstruction
3. A 12 month study of the placebo effect in transurethral microwave thermotherapy
4. Transurethral microwave thermotherapy (TUMT) in benign prostatic hyperplasia: Placebo versus TUMT
5. Current status of thermotherapy of the prostate
6. Three-year followup of patients treated with lower energy microwave thermotherapy
7. Transurethral microwave thermotherapy for benign prostatic hyperplasia
8. United States Prostatron TUMT Study - 4 year followup and quality of life
9. Microwave thermotherapy: A long-term follow-up of 67 patients from a single center
10. Long-term results of lower energy transurethral microwave thermotherapy
11. Serum concentrations of prostate-specific antigen after diagnostic procedures and transurethral microwave thermotherapy of benign prostatic hyperplasia
12. Transurethral microwave thermotherapy for management of benign prostatic hyperplasia: One-year results with the PRIMUS U + R device
13. Three-year follow-up after transurethral microwave thermotherapy (TUMT) for management of benign prostatic hyperplasia using the PRIMUS U + R device
14. Mortality and reoperation after open and transurethral resection of the prostate for benign prostatic hyperplasia
15. The effect of prostatectomy on symptom severity and quality of life
16. Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia
17. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia
18. The efficacy of terazosin, finasteride, or both in benign prostatic hyperplasia
19. Does transurethral thermotherapy induce a long-term alpha blockade?
20. Transurethral microwave thermotherapy: Past, present and future
21. The heat is on - But how? A comparison of TUMT devices
22. Contrasting heating patterns and efficiency of the Prostatron and Targis microwave antennae for thermal treatment of benign prostatic hyperplasia
23. Intraprostatic temperature monitoring during transurethral microwave thermotherapy for the treatment of benign prostatic hyperplasia